Keiichiro Okuda

Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells

Seita Kataoka, Atsushi Umemura, Keiichiro Okuda et al. · International Journal of Molecular Sciences · 2021 · 34 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease

Yuya Seko, Kanji Yamaguchi, Naoki Mizuno et al. · Journal of Gastroenterology · 2017 · 28 citations

Medicine, Genetics, Molecular Genetics +15

Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis

Keiichiro Okuda, Atsushi Umemura, Seita Kataoka et al. · Cancers · 2021 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells

Aya Takahashi, Atsushi Umemura, Kota Yano et al. · Frontiers in Oncology · 2021 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress

Keiichiro Okuda, Atsushi Umemura, Seita Kataoka et al. · Frontiers in Oncology · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +16